CPT® Code 90380

The CPT® Code 90380 refers to a specific monoclonal antibody vaccine designed to provide protection against respiratory syncytial virus (RSV). This vaccine is administered in a seasonal dose of 0.5 mL via intramuscular injection. The primary function of this vaccine is to stimulate the recipient's immune system to produce antibodies that can effectively combat RSV, a virus known for causing acute respiratory infections, particularly in vulnerable populations such as infants, young children, and individuals with compromised immune systems or pre-existing respiratory conditions. RSV is notably seasonal, with higher circulation rates during the fall and winter months, making timely vaccination crucial for at-risk groups. The monoclonal antibody contained in this vaccine is engineered to mimic the natural immune response, thereby enhancing the body’s ability to recognize and fight off the virus upon subsequent exposures. It is particularly important for infants and neonates entering their first RSV season, as they are at a heightened risk for severe illness, including pneumonia and hospitalization. The administration of this vaccine is a preventive measure aimed at reducing the incidence of RSV-related complications in these high-risk populations.